Michael Lanuti
Papers
3
Total Citations
37
H-Index
3
About
Dr. Michael Lanuti is a leading thoracic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques and personalized treatment strategies for non-small cell lung cancer (NSCLC). His major contributions include pioneering the use of ultrasonic energy for pulmonary artery branch sealing in video-assisted thoracoscopic surgery (VATS) lobectomy, demonstrated in a prospective, multicenter, international phase 2 trial (23 citations). This work has helped refine safer, more efficient surgical approaches. Dr. Lanuti has also conducted a systematic review on sublobar resection for high-risk patients with stage I NSCLC (7 citations), providing critical evidence for tailoring surgery to patient frailty. Notably, he led a first-in-human study implanting multidrug-eluting microdevices directly into NSCLC tumors to test chemotherapeutic sensitivity *in situ* (7 citations), a proof-of-concept that could revolutionize personalized adjuvant therapy by predicting optimal drug regimens before systemic treatment. His research bridges surgical innovation and precision oncology, directly impacting clinical decision-making for lung cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3